Cardiometabolic Burden in Bilateral Macronodular Adrenal Disease With Primary Aldosteronism.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Panarelli Annalisa, Araujo-Castro Marta, Mermejo Livia M, Turcu Adina F, Kim Jung Hee, Park Seung Shin, Bioletto Fabio, Parasiliti-Caprino Mirko, Sone Masakatsu, Markou Athina, Puar Troy, Kmieć Piotr, Mulatero Paolo, Wada Norio, Tsuiki Mika, González-Boillos Marga, Jimenez López Noemi, Yoneda Takashi, Ceccato Filippo, de Castro Margaret, Espiard Stéphanie, Ichijo Takamasa, Izawa Shoichiro, Murakami Masanori, Palmieri Serena, Favero Vittoria, Katabami Takuyuki, Falhammar Henrik, Naruse Mitsuhide, Quinkler Marcus, Reincke Martin, Nowak Elisabeth
Аннотация
METHODS: This international (Europe, United States, Asia) retrospective cohort study included adults with radiological evidence of bilateral macronodular adrenocortical disease and biochemically confirmed PA. The primary endpoints was major adverse cardiovascular events (MACE); secondary end points included cardiometabolic comorbidities and surgical outcomes per PA surgical outcome criteria.
RESULTS: Two hundred forty-nine patients from 41 centers in 12 countries were included (median age, 55 years; 62% male). Median hypertension duration at PA diagnosis was 9.9 years. Among 178 tested, 52% had cortisol cosecretion and 47% isolated PA. At baseline, 56% had metabolic comorbidities, and 16% had ≥1 MACE. Patients with MACE were older, more often male, had longer hypertension duration, and higher diabetes rates. Eighty-nine patients underwent adrenalectomy: 50 without MRA (mineralocorticoid receptor antagonists), 38 with MRA, and 1 with steroidogenesis inhibitors. One hundred twenty-four patients received continued MRA without adrenalectomy or steroidogenesis inhibitors. Adrenal venous sampling showed lateralized PA in 89% of surgical versus 19% of MRA-treated patients (P<0.001). Over a median follow-up of 36 (MRA) and 18 months (surgery; P=0.2), MACE occurred in 8% and 6%, respectively (P=1.0). Blood pressure and organ damage were similar, but more MRA-treated patients needed ≥3 antihypertensives (MRA: 48% versus adrenalectomy: 14%; P<0.001). Among operated patients, complete clinical and biochemical success was 26% and 71%, respectively.
CONCLUSIONS: Bilateral macronodular adrenocortical disease with PA carries a high cardiometabolic burden. Early detection and precise subtyping are key to optimizing management and preventing target organ damage.